Human cytomegalovirus may promote tumour progression by upregulating arginase-2-Reference-Cited by-同舟云学术

Human cytomegalovirus may promote tumour progression by upregulating arginase-2

Published:2016-05-30 Issue:30 Volume:7 Page:47221-47231
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Costa Helena¹,Xu Xinling¹,Overbeek Gitta¹,Vasaikar Suhas²,Patro C. Pawan K.³,Kostopoulou Ourania N.¹,Jung Masany¹,Shafi Gowhar⁴,Ananthaseshan Sharan¹,Tsipras Giorgos²,Davoudi Belghis¹,Mohammad Abdul-Aleem¹,Lam Hoyin¹⁵,Strååt Klas¹⁶,Wilhelmi Vanessa¹,Shang Mingmei²,Tegner Jesper²,Tong Joo Chuan³,Wong Kum Thong⁷,Söderberg-Naucler Cecilia¹,Yaiw Koon-Chu¹

Affiliation:

1. Cell and Molecular Immunology, Department of Medicine, Center for Molecular Medicine, Unit for Experimental Cardiovascular Research and Department of Neurology, Karolinska Institutet, Stockholm, Sweden

2. Unit of Computational Medicine, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

3. Social & Cognitive Computing Department, Institute of High Performance Computing, Agency for Science, Technology and Research, Singapore

4. Department of Genomics and Bioinformatics, Positive Bioscience, Mumbai, India

5. Present affiliation: Division of Cancer Studies, King's College London, London, UK

6. Division of Gene Technology, School of Biotechnology, Science for Life Laboratory, Royal Institute of Technology (KTH), Solna, Sweden

7. Department of Pathology, Faculty of Medicine, University of Malaya, Malaysia

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Friend or Foe? Exploring the Role of Cytomegalovirus (HCMV) Infection in Head and Neck Tumors;Biomedicines;2024-04-15

2. Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy;International Journal of Molecular Sciences;2024-03-27

3. Ginsenoside Rg1 as a promising adjuvant agent for enhancing the anti-cancer functions of granulocytes inhibited by noradrenaline;Frontiers in Immunology;2023-02-01

4. Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression;ESMO Open;2022-12

5. Arginase: An emerging and promising therapeutic target for cancer treatment;Biomedicine & Pharmacotherapy;2022-05